- Home
- LTRN vs TXMD Comparison
LTRN vs TXMD Comparison
Compare LTRN & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LTRN | TXMD |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.6M | 24.3M |
| IPO Year | 2020 | 2012 |
Fundamental Metrics
Financial Performance| Metric | LTRN | TXMD |
|---|---|---|
| Price | $1.22 | $2.07 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 211.2K | 20.5K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 18.65 | ★ 73.68 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $1,761,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $106.50 |
| Revenue Growth | N/A | ★ 35.25 |
| 52 Week Low | $1.11 | $0.99 |
| 52 Week High | $4.70 | $2.95 |
Technical Indicators
Market Signals| Indicator | LTRN | TXMD |
|---|---|---|
| Relative Strength Index (RSI) | 23.28 | 41.59 |
| Support Level | $1.11 | $1.95 |
| Resistance Level | $1.96 | $2.16 |
| Average True Range (ATR) | 0.17 | 0.07 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 8.82 | 14.78 |
Price Performance
Historical ComparisonAbout LTRN Lantern Pharma Inc.
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.